1 Min Read
* INSYS THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS
* Q4 EARNINGS PER SHARE VIEW $-0.14 — THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.